Statement of Chair Lina M. Khan Regarding Solicitation for Public Comments on the Infant Formula Shortage
Date
By
Lina M. Khan, Former Chair and Commissioner
The FTC’s five Commissioners issue statements on a range of important topics to engage with the public and express the views of the Commission as well as their own individual views.
Displaying 301 - 320 of 1028
Statement of Chair Lina M. Khan Regarding Policy Statement on Education Technology and the Children's Online Privacy Protection Act
Date
By
Lina M. Khan, Former Chair and Commissioner
Matter Number
P155401
Statement of Commissioner Alvaro Martin Bedoya Regarding the Policy Statement on Education Technology and COPPA
Date
By
Alvaro Bedoya, Former Commissioner
Matter Number
P155401
File
Text of the Statement by Commissioner Bedoya
(155.17 KB)
Statement of Chair Lina M. Khan Regarding the Endorsement Guides Review
Date
By
Lina M. Khan, Former Chair and Commissioner
Matter Number
P204500
File
Text of the Statement of Chair Khan
(180.26 KB)
Statement of Chair Lina M. Khan in the Matter of R360 Network LLC
Date
By
Lina M. Khan, Former Chair and Commissioner
Matter Number
1823171
File
Written Submission on the Public Interest of Chair Lina M. Khan and Commissioner Rebecca Kelly Slaughter in the Matter of Certain UMTS and LTE Cellular Communication Modules
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
Written Submission to the U.S. International Trade Commission
File
Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding the Commission's Fiscal Year 2023 Budget Request to Congress
Date
By
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
P859900
Joint statement by Federal Trade Commission Chair Lina Khan and Didier Reynders, Commissioner for Justice of the European Commission
Date
By
Lina M. Khan, Former Chair and Commissioner
Concurring Statement of Commissioner Slaughter and Chair Khan regarding FTC and State of Rhode Island v. Lifespan Corporation and Care New England Health System
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
2110031
File
Concurring Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding Lifespan Corporation and Care New England Health System
Date
By
Christine S. Wilson, Former Commissioner;
Noah Joshua Phillips, Former Commissioner
Matter Number
211 0031
Docket Number
9406
File
Text of the Statement
(161.54 KB)
Comment Submission of Chair Lina M. Khan Regarding the 1995 Bank Merger Competitive Review Guidelines
Date
By
Lina M. Khan, Former Chair and Commissioner
Joint Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding Grant of Prior Approval Application of Sartorius Stedim Biotech S.A. for the Acquisition of Novasep Process SAS
Date
By
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
C4710
Statement of Commissioner Rebecca Kelly Slaughter in the Matter of Vision Path, Inc. D/b/a Hubble
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Concurring Statement of Commissioner Rebecca Kelly Slaughter, Joined by Chair Lina M. Khan, Regarding the 2022 Revised Clayton Act Thresholds
Date
By
Rebecca Kelly Slaughter, Former Commissioner;
Lina M. Khan, Former Chair and Commissioner
Matter Number
P859910
Displaying 301 - 320 of 1028